Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. WuXi AppTec Co., Ltd.
  6. News
  7. Summary
    603259   CNE1000031K4

WUXI APPTEC CO., LTD.

(603259)
  Report
End-of-day quote. End-of-day quote Shanghai Stock Exchange - 10/15
145.33 CNY   +1.01%
10/06SIRONA BIOCHEM : On Advancement of TFC-1067 Compound
MT
09/22DMD : Charting the Path for New Therapeutics and Better Care
PU
08/25WUXI APPTEC : Investor Day - Financial Performance
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

WuXi AppTec : Investor Day - WuXi Testing

08/25/2021 | 04:31pm EDT

WuXi Testing:

End-to-End Testing Platform

Dr. Steve Yang

Co-CEO

WuXi Testing: C"T"DMO Platform for All Modalities

Discovery

Pre-Clinical

Small Molecule

Biologics, Cell / Gene Therapy

WuXi Chemistry & WuXi Biologics

Pre-Clinical Testing

WuXi

Testing

Clinical Testing

Commercial

Clinical

  • WIND
  • DMPK
  • Toxicology
  • Bioanalysis
  • Medical Device Testing
  • Clinical CRO
  • Clinical SMO

Strong Synergy with WuXi Chemistry and WuXi Biologics

Client Number Overlap between

IND Number Overlap between

WuXi Chemistry and WuXi Testing

WuXi Biologics and WuXi Testing

50%

1500+

200

66

600+

WuXi

Chemistry

Client No.

WuXi

WuXi

Testing

Biologics

IND No.

WuXi

Testing

WuXi Testing: Enable Faster Value Creation for Customers

PCC

IND

POC

NDA

Approval

Preclinical

Early Clinical

Late Clinical

Regulatory

Enable faster project progression

and value creation

from pre-clinical to POC and NDA

PCC

IND

POC

NDA

Approval

Preclinical

Early Clinical

Late Clinical

Regulatory

CRO

Preclinical

SMO

WuXi Testing: Leadership Team

Xu Hui

Jin Yi

Bill Harrison

Shen Liang

Shi Jing

VP, Head of Operation &

VP, Head of PM & RA

VP, Head of Toxicology

VP, Head of DMPK

VP, Head of Bioanalytical

Domestic BD

Chief Scientific Toxicologist

Service

Steve Yang

Co-CEO

Head of WuXi Testing

Ed Amat

LAN LI

Johnathan Lee

Reako Ren

Michael Hui

Mike McGrew

VP, Head of Int'l BD

VP, Head of CL

VP, Head of WuXi Clinical

VP, Head of SMO

VP, Head of QA

VP, Head of Medical Device

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

WuXi AppTec Co. Ltd. published this content on 23 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 August 2021 20:30:09 UTC.


ę Publicnow 2021
All news about WUXI APPTEC CO., LTD.
10/06SIRONA BIOCHEM : On Advancement of TFC-1067 Compound
MT
09/22DMD : Charting the Path for New Therapeutics and Better Care
PU
08/25WUXI APPTEC : Investor Day - Financial Performance
PU
08/25WUXI APPTEC : Investor Day - Industry Trend and Company Strategy
PU
08/25WUXI APPTEC : Investor Day - WuXi Biology
PU
08/25WUXI APPTEC : Investor Day - WuXi Chemistry
PU
08/25WUXI APPTEC : Investor Day - WuXi Testing
PU
08/13WUXI APPTEC : H1 Profit Surges 56% on Strong Revenue
MT
08/12WuXi AppTec Co., Ltd. Announces Earnings Results for the Half Year Ended June 30, 2021
CI
08/12WUXI APPTEC : Reports Strong 2021 Interim Results
PU
More news
Analyst Recommendations on WUXI APPTEC CO., LTD.
More recommendations
Financials
Sales 2021 22 610 M 3 514 M 3 514 M
Net income 2021 4 383 M 681 M 681 M
Net cash 2021 8 003 M 1 244 M 1 244 M
P/E ratio 2021 95,2x
Yield 2021 0,28%
Capitalization 426 B 66 184 M 66 192 M
EV / Sales 2021 18,5x
EV / Sales 2022 14,0x
Nbr of Employees 28 542
Free-Float 58,3%
Chart WUXI APPTEC CO., LTD.
Duration : Period :
WuXi AppTec Co., Ltd. Technical Analysis Chart | 603259 | CNE1000031K4 | MarketScreener
Technical analysis trends WUXI APPTEC CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Last Close Price 145,33 CNY
Average target price 185,18 CNY
Spread / Average Target 27,4%
EPS Revisions
Managers and Directors
Min Zhang Chen Co-Chief Executive Officer
Qing Yang Co-CEO, Executive Director & Executive VP
Ge Li Chairman & President
Ellis Chu Chief Financial Officer & Senior Vice President
Harry He Chairman-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
WUXI APPTEC CO., LTD.29.45%66 184
GILEAD SCIENCES, INC.16.08%84 795
BIONTECH SE203.83%59 820
REGENERON PHARMACEUTICALS14.52%57 519
VERTEX PHARMACEUTICALS-23.09%47 156
BEIGENE, LTD.38.72%33 452